A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease

NCT06343636 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Alzheimer Disease

Interventions

DRUG: VG-3927
DRUG: Placebo
DRUG: VG-3927

Sponsor

Vigil Neuroscience, Inc.